APOE4, Breast Cancer Treatment, and Cognitive Impairment Risk
The following is a summary of “Interaction between APOE Ɛ4 status, chemotherapy and...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 12173 results for 'cancer treatment'
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment.
The use of complementary and alternative medications (CAM) is popular among cancer patients. CAM includes vitamins, minerals, phytotherapy, homeopathy, nutritional supplements and probiotics. CAM use may lead to unwanted risks...
Read More
Feasibility of Digital and Nurse-Led Support After Prostate Cancer Treatment
The following is a summary of “A digital and nurse-led support intervention, first year after...
Read More
Efficacy of ICI in Bladder Cancer Treatment
The following is a summary of “Immune checkpoint inhibitor therapy as a neoadjuvant treatment for...
Read More
Outcomes of Laparoscopic and Open Surgery in Kidney Cancer Treatment
The following is a summary of “Open versus mini-invasive partial and radical nephrectomy...
Read More
Comparison of Midline and Leg Lymphoedema after Prostate Cancer Treatment
The following is a summary of “Characteristics of lymphoedema, in particular midline lymphoedema,...
Read More
Impact of Critical Illness on Anticancer Treatment Continuation in Patients With AML & B-NHL
The following is a summary of “Impact of critical illness on continuation of anticancer treatment...
Read More
Survival Outcomes and Cancer Treatment Post-ICU Stay
The following is a summary of “Factors associated with cancer treatment resumption after ICU stay...
Read More
Increasing Stereotactic Body Radiation Adoption Impacts Prostate Cancer Treatment Patterns
The following is a summary of “Stereotactic Body Radiation Adoption Impacts Prostate Cancer...
Read MoreAdvertisement
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy Outcomes
MONDAY, July 8, 2024 (HealthDay News) — In a trial involving patients with...
Read MoreClinical applications of telemedicine services using a regional telemedicine platform for cancer treatment: a cross-sectional study.
Telemedicine is beneficial for improving treatment efficiency and reducing medical expenses of cancer patients. This study focuses on cancer patients participating in teleconsultations through a regional telemedicine platform in...
Read More
MR-Guided Radiotherapy Worsens Patient-Reported Urinary and Bowel Symptoms for First Month Post-Prostate Cancer Treatment vs Pre-Radiotherapy
The following is a summary of “Patient-reported outcomes following MR-guided radiotherapy for...
Read More
Exploiting Selective Drug Targets for Cancer Treatment Through Methylation Synthetic Lethality
The following is a summary of “Methylation synthetic lethality: Exploiting selective drug targets...
Read More
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 (HealthDay News) — There are systemic disparities in definitive cancer...
Read More
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
THURSDAY, May 9, 2024 (HealthDay News) — For patients with breast cancer, there are racial...
Read More
PGC Results in Fivefold Higher Risk of Prostate Cancer Treatment Failure vs. Robotic RP
The following is a summary of “Comparative Effectiveness of Partial Gland Cryoablation Versus...
Read More
Patient Enrollment in Cancer Treatment Trials About 7 Percent
TUESDAY, April 16, 2024 (HealthDay News) — Patient enrollment in cancer treatment trials is...
Read More
Utilizing Aptamers for Targeted Therapy in Cancer Treatment
The following is a summary of “Aptamers as an approach to targeted cancer therapy,” published in...
Read More
Elevated Hepatotoxicity Risk Linked to Cabozantinib in Cancer Treatment
The following is a summary of “Higher risk of hepatotoxicity associated with cabozantinib in...
Read More
Nivolumab Plus Chemotherapy Continues to Deliver Efficacy in Gastric Cancer Treatments
Four-year follow-up data demonstrates the benefits of nivolumab plus chemotherapy over chemotherapy alone in newly diagnosed patients with advanced gastric cancer.
Read More